메뉴 건너뛰기




Volumn 49, Issue 7, 2009, Pages 1006-1008

What is inadequate antibacterial therapy?

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; FUSIDIC ACID; RIFAMPICIN; SULFONAMIDE; TRIMETHOPRIM; VANCOMYCIN;

EID: 70349906748     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/605556     Document Type: Note
Times cited : (6)

References (20)
  • 1
    • 70349895547 scopus 로고    scopus 로고
    • Adequacy of antimicrobial treatment and outcome of staphylococcus aureus bacteremia in 9 western european countries
    • (in this issue)
    • Ammerlaan H, Seifert H, Harbarth S, et al. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. Clin Infect Dis 2009; 46:997-1005 (in this issue).
    • (2009) Clin Infect Dis , vol.46 , pp. 997-1005
    • Ammerlaan, H.1    Seifert, H.2    Harbarth, S.3
  • 2
    • 0141610906 scopus 로고    scopus 로고
    • The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting
    • Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-155 (Pubitemid 30485502)
    • (2000) Chest , vol.118 , Issue.1 , pp. 146-155
    • Ibrahim, E.H.1    Sherman, G.2    Ward, S.3    Fraser, V.J.4    Kollef, M.H.5
  • 5
    • 0038468773 scopus 로고    scopus 로고
    • Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia
    • Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36: 1418-1423
    • (2003) Clin Infect Dis , vol.36 , pp. 1418-1423
    • Lodise, T.P.1    McKinnon, P.S.2    Swiderski, L.3    Rybak, M.J.4
  • 6
    • 49749199257 scopus 로고
    • Natural history of 338 treated and untreated patients with staphylococcal septicaemia (1936-1955)
    • Smith IM, Vickers AB. Natural history of 338 treated and untreated patients with staphylococcal septicaemia (1936-1955). Lancet 1960; 275:1318-1322
    • (1960) Lancet , vol.275 , pp. 1318-1322
    • Smith, I.M.1    Vickers, A.B.2
  • 7
    • 70349973235 scopus 로고
    • Acute osteomyelitis with staphylococcemia: A clinical report on the use of antitoxin in its treatment
    • Baker LD, Shands AR Jr. Acute osteomyelitis with staphylococcemia: a clinical report on the use of antitoxin in its treatment. JAMA 1939; 113:2119-2124
    • (1939) JAMA , vol.113 , pp. 2119-2124
    • Baker, L.D.1    Shands Jr., A.R.2
  • 9
    • 70349970607 scopus 로고
    • Treatment of staphylococcal septicemia with sulfamethylthiazole and sulfathiazole: A report of twelve cases
    • Hamburger M, Ruegsegger JM. Treatment of staphylococcal septicemia with sulfamethylthiazole and sulfathiazole: a report of twelve cases. Ann Intern Med 1941; 14:1137-1154
    • (1941) Ann Intern Med , vol.14 , pp. 1137-1154
    • Hamburger, M.1    Ruegsegger, J.M.2
  • 10
    • 0000232105 scopus 로고
    • Significance of bacteremia caused by Staphylococcus aureus: A study of one hundred and twenty-two cases and a review of the literature concerned with experimental infection in animals
    • Skinner D, Keefer CS. Significance of bacteremia caused by Staphylococcus aureus: a study of one hundred and twenty-two cases and a review of the literature concerned with experimental infection in animals. Arch Intern Med 1941; 68:851-875
    • (1941) Arch Intern Med , vol.68 , pp. 851-875
    • Skinner, D.1    Keefer, C.S.2
  • 11
    • 33846161259 scopus 로고    scopus 로고
    • Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus
    • DOI 10.1086/510396
    • Stevens DL, Ma Y, Salmi DB, McIndoo E, Wallace RJ, Bryant AE. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillinresistant Staphylococcus aureus. J Infect Dis 2007; 195:202-211 (Pubitemid 46080052)
    • (2007) Journal of Infectious Diseases , vol.195 , Issue.2 , pp. 202-211
    • Stevens, D.L.1    Ma, Y.2    Salmi, D.B.3    McIndoo, E.4    Wallace, R.J.5    Bryant, A.E.6
  • 12
    • 34247114984 scopus 로고    scopus 로고
    • Effect of antibiotics on staphylococcus aureus producing panton-valentine leukocidin
    • Dumitrescu O, Boisset S, Badiou C, et al. Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin. Antimicrob Agents Chemother 2007; 51:1515-1519
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 1515-1519
    • Dumitrescu, O.1    Boisset, S.2    Badiou, C.3
  • 14
    • 0036635876 scopus 로고    scopus 로고
    • Staphylococcus aureus sepsis in hospitalized non-neutropenic patients: Retrospective clinical and microbiological analysis
    • Falcone M, Carfagna P, Cassone M, et al. Staphylococcus aureus sepsis in hospitalized non-neutropenic patients: retrospective clinical and microbiological analysis. Ann Ital Med Int 2002; 17:166-172
    • (2002) Ann Ital Med Int , vol.17 , pp. 166-172
    • Falcone, M.1    Carfagna, P.2    Cassone, M.3
  • 15
    • 50949085411 scopus 로고    scopus 로고
    • Relationship between vancomycin MIC and failure among patients with methicillin-resistant staphylococcus aureus bacteremia treated with vancomycin
    • Lodise TP, Graves J, Evans A, et al. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 2008;52:3315-3320
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 3315-3320
    • Lodise, T.P.1    Graves, J.2    Evans, A.3
  • 16
    • 39449112495 scopus 로고    scopus 로고
    • Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant taphylococcus aureus bacteremia
    • Soriano A, Marco F, Martinez JA, et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 46:193-200.
    • (2008) Clin Infect Dis , vol.46 , pp. 193-200
    • Soriano, A.1    Marco, F.2    Martinez, J.A.3
  • 17
    • 61849122341 scopus 로고    scopus 로고
    • Clinical features of heteroresistant vancomycin-intermediate staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia
    • Maor Y, Hagin M, Belausov N, Keller N, BenDavid D, Rahav G. Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia. J Infect Dis 2009; 199:619-624
    • (2009) J Infect Dis , vol.199 , pp. 619-624
    • Maor, Y.1    Hagin, M.2    Belausov, N.3    Keller, N.4    Bendavid, D.5    Rahav, G.6
  • 18
    • 29244439618 scopus 로고    scopus 로고
    • Adaptation of methicillin-resistant staphylococcus aureus in the face of vancomycin therapy
    • Sakoulas G, Moellering RC Jr, Eliopoulos GM. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy. Clin Infect Dis 2006; 42:S40-51.
    • (2006) Clin Infect Dis , vol.42
    • Sakoulas, G.1    Moellering Jr., R.C.2    Eliopoulos, G.M.3
  • 19
    • 34247282090 scopus 로고    scopus 로고
    • The rationale for revising the clinical and laboratory standards institute vancomycin minimal inhibitory concentration interpretive criteria for staphylococcus aureus
    • Tenover FC, Moellering RC Jr. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis 2007; 44:1208-1215
    • (2007) Clin Infect Dis , vol.44 , pp. 1208-1215
    • Tenover, F.C.1    Moellering Jr., R.C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.